Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Antidotes01:17

Antidotes

1.4K
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
1.4K
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

2.0K
Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
2.0K
Toxidromes: Clinical Features01:30

Toxidromes: Clinical Features

175
Toxidromes are specific patterns of symptoms resulting from toxic substance exposure. They help in the identification and treatment of poisoning. The symptoms of each toxidrome group indicate poisoning by a certain class of chemicals or drugs.1. Sympathomimetic: Stimulates the sympathetic nervous system. Symptoms include agitation, increased heart rate (HR), blood pressure (BP), respiratory rate (RR), temperature, and pupil size. Drugs like cocaine and amphetamines, along with tremors and...
175
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116
Pharmaceutical Poisoning: Treatment Strategies01:26

Pharmaceutical Poisoning: Treatment Strategies

279
Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
279
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

53
DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic...
53

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biochemical analysis of a TrkB receptor mutation that causes a developmental epileptic encephalopathy.

The Journal of biological chemistry·2026
Same author

Circuit-specific gene editing for precision modulation of neuronal activity with CRISPR-rabies virus.

bioRxiv : the preprint server for biology·2025
Same author

Toward the full potential of mRNA therapeutics.

Molecular therapy : the journal of the American Society of Gene Therapy·2024
Same author

A simple, automated method of seizure detection in mouse models of temporal lobe epilepsy.

Epilepsy research·2023
Same author

Correction to: A fluorogenic micrococcal nuclease‑based probe for fast detection and optical imaging of Staphylococcus aureus in prosthetic joint and fracture‑related infections.

European journal of nuclear medicine and molecular imaging·2023
Same author

A fluorogenic micrococcal nuclease-based probe for fast detection and optical imaging of Staphylococcus aureus in prosthetic joint and fracture-related infections.

European journal of nuclear medicine and molecular imaging·2023

Related Experiment Video

Updated: May 3, 2026

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
15:05

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons

Published on: February 5, 2015

11.6K

Ischemic stroke: "acidotoxicity" is a perpetrator.

Yangzhong Huang1, James O McNamara

  • 1Department of Neurobiology, Duke University Medical Center, Durham, NC 27710, USA.

Cell
|September 17, 2004
PubMed
Summary

Acidosis damages the brain during ischemic stroke, a major neurological disease. Xiong et al. (2004) reveal a key molecular mechanism behind this brain damage in ischemia.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Pathophysiology

Background:

  • Ischemic stroke is a leading cause of death and disability worldwide.
  • The precise molecular mechanisms underlying brain damage during ischemia remain incompletely understood.
  • Acidosis is a common condition observed during ischemic events.

Discussion:

  • This study by Xiong et al. (2004) in Cell identifies a specific molecular pathway through which acidosis contributes to neuronal injury.
  • The findings shed light on the complex interplay between metabolic disturbances and neurological damage in the context of stroke.
  • Understanding these mechanisms is crucial for developing targeted therapeutic interventions.

Key Insights:

  • Acidosis directly damages brain tissue during ischemic stroke.

More Related Videos

Establishment of Acute Pontine Infarction in Rats by Electrical Stimulation
05:02

Establishment of Acute Pontine Infarction in Rats by Electrical Stimulation

Published on: August 27, 2020

5.4K
Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry
10:58

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry

Published on: September 27, 2020

4.6K

Related Experiment Videos

Last Updated: May 3, 2026

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons
15:05

Functional Evaluation of Biological Neurotoxins in Networked Cultures of Stem Cell-derived Central Nervous System Neurons

Published on: February 5, 2015

11.6K
Establishment of Acute Pontine Infarction in Rats by Electrical Stimulation
05:02

Establishment of Acute Pontine Infarction in Rats by Electrical Stimulation

Published on: August 27, 2020

5.4K
Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry
10:58

Targeted Neuronal Injury for the Non-Invasive Disconnection of Brain Circuitry

Published on: September 27, 2020

4.6K
  • A novel molecular mechanism linking acidosis to ischemic brain injury has been elucidated.
  • This research provides a foundation for future studies on acidosis-related neurological damage.

    • Outlook:

    • Further research is warranted to explore potential therapeutic strategies targeting the identified molecular pathway.
    • Investigating the role of acidosis in other neurological conditions may reveal new insights.
    • Translational studies are needed to assess the clinical relevance of these findings.